Skip to main content

American Journal of Cardiovascular Drugs OnlineFirst articles

15.05.2024 | Commentary

Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists

verfasst von:
Teresa Vezza, Víctor M. Víctor

11.05.2024 | Systematic Review

Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials

Obesity is a multifaceted condition, with an increasing incidence and prevalence worldwide [ 1 ]. Treatment options for obesity are currently limited, and the condition is associated with a higher risk of dyslipidemia, type 2 diabetes mellitus …

verfasst von:
Gustavo de Oliveira Almeida, Thiago Faraco Nienkötter, Caroline Cristine Almeida Balieiro, Eric Pasqualotto, Júlia Braga Cintra, Henrique Champs Porfírio Carvalho, Ana Laura Soares Silva, Júlia Camargo Kabariti, Bárbara Silvestre Minucci, Edmundo Damiani Bertoli, Camila Mota Guida

07.05.2024 | Systematic Review

Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Cardiovascular disease is the primary cause of death worldwide and a major cause of disability [ 1 ]. Extensive evidence from epidemiological, genetic, and randomized interventional clinical studies has consistently established a correlation …

verfasst von:
Hussain Sohail Rangwala, Hareer Fatima, Mirha Ali, Muhammad Ashir Shafiq, Burhanuddin Sohail Rangwala, Vikash Virwani, Aashish Kumar, Syed Ali Arsal, Adarsh Raja, Sandesh Raja, Muhammad Saqlain Mustafa